Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

Preclinical investigation and clinical experience have provided evidence on the potential anticancer effect of artemisinin and its derivatives (ARTs) in the recent two decades. The major mechanisms of action of ARTs may be due to toxic-free radicals generated by an endoperoxide moiety, cell cycle ar...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Zhe Li, Qin Li, Jun Wu, Manyuan Wang, Junxian Yu
Materialtyp: Artikel
Språk:English
Publicerad: MDPI AG 2016-10-01
Serie:Molecules
Ämnen:
artemisinin
anticancer activity
repurposed
specific drug delivery system
clinical trials
Länkar:http://www.mdpi.com/1420-3049/21/10/1331

Internet

http://www.mdpi.com/1420-3049/21/10/1331

Liknande verk